Exercise Treatment for Traumatic Brain Injury
((TOBI-SET) Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a special exercise program, Sub-symptomatic Adaptable Exercise Treatment (SAET), might aid those with mild traumatic brain injuries (mTBI) in feeling better and resuming daily activities. The research aims to determine if this tailored exercise plan, designed to avoid worsening symptoms, is more effective than simple stretching exercises. Participants will engage in regular exercise sessions intended to enhance mental health and physical functioning. The trial seeks active service members who have experienced ongoing symptoms after at least one mild traumatic brain injury a month or more ago. As an unphased trial, it offers participants the chance to contribute to innovative research that could improve recovery strategies for mTBI.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exercise treatment is safe for individuals with traumatic brain injury?
Research has shown that Sub-symptomatic Adaptable Exercise Treatment (SAET) is generally safe for individuals with mild traumatic brain injury (mTBI). Studies have found that exercising at a level that does not exacerbate symptoms can help alleviate ongoing symptoms experienced after a brain injury. These exercises are carefully adjusted to prevent symptom aggravation during activity.
One study involving individuals with mTBI demonstrated that aerobic exercise, performed without worsening symptoms, reduced symptoms and improved daily life. Participants reported no major negative effects from the exercise program, indicating it is well-tolerated.
In summary, SAET appears to be a safe method for managing symptoms after a mild brain injury. It emphasizes staying within safe limits to avoid symptom exacerbation while still reaping the benefits of exercise.12345Why are researchers excited about this trial?
Researchers are excited about the Sub-symptomatic Adaptable Exercise Treatment (SAET) for traumatic brain injury because it customizes exercise intensity to each participant's symptoms, adjusting the workout to stay below the threshold where symptoms might increase. This personalized approach is different from standard care, which often relies on general physical therapy and rest without such tailored adaptability. Additionally, SAET combines both aerobic and resistance training, which is not typically emphasized in regular treatment plans, offering a comprehensive exercise regimen that targets multiple aspects of recovery.
What evidence suggests that this trial's treatments could be effective for mTBI?
Research has shown that Sub-symptomatic Adaptable Exercise Treatment (SAET), which participants in this trial may receive, can help individuals with mild traumatic brain injury (mTBI) by reducing symptoms and improving overall function. A key component of SAET involves aerobic exercise that remains below the symptom-triggering threshold. This exercise type has proven safe and effective in reducing post-concussion symptoms and aiding individuals in returning to their usual activities. Studies also indicate that this exercise method can enhance exercise tolerance and lessen symptom intensity. These benefits suggest that SAET could be a promising option for those who continue to experience issues after an mTBI.12367
Who Is on the Research Team?
Jason M Bailie, Phd
Principal Investigator
Traumatic Brain Injury Center of Excellence (TBICoE)
Are You a Good Fit for This Trial?
This trial is for military service members (SMs) who have experienced a mild traumatic brain injury (mTBI), commonly known as a concussion, and are still dealing with symptoms. The program aims to be adaptable for individual medical needs and available resources.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Sub-symptomatic Adaptable Exercise Treatment (SAET) or the Stretching Control Group (SCG) intervention for 8 weeks, with sessions conducted both in-clinic and independently.
Follow-up
Participants are monitored for changes in neurobehavioral symptoms, cognitive impairment, physiological adaptation, and occupational performance.
What Are the Treatments Tested in This Trial?
Interventions
- Stretching Control Group (SCG)
- Sub-symptomatic Adaptable Exercise Treatment (SAET)
Find a Clinic Near You
Who Is Running the Clinical Trial?
United States Naval Medical Center, San Diego
Lead Sponsor